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Protein arginine methyltransferase 1 (PRMT1) catalyzes the asymmetric dimethylation of arginine res-
idues in proteins and methylation of various RNA-binding proteins and is associated with alternative
splicing in vitro. Although PRMT1 has essential in vivo roles in embryonic development, CNS develop-
ment, and skeletal muscle regeneration, the functional importance of PRMT1 in the heart remains to
be elucidated. Here, we report that juvenile cardiomyocyte-specific PRMT1-deficient mice develop se-
vere dilated cardiomyopathy and exhibit aberrant cardiac alternative splicing. Furthermore, we iden-
tified previously undefined cardiac alternative splicing isoforms of four genes (Asb2, Fbxo40, Nrap,
and Eif4a2) in PRMT1-cKO mice and revealed that eIF4A2 protein isoforms translated from alterna-
tively spliced mRNAwere differentially ubiquitinated and degraded by the ubiquitin-proteasome sys-
tem. These findings highlight the essential roles of PRMT1 in cardiac homeostasis and alternative
splicing regulation.
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Arginine methylation, a post-translational modification, is found in a broad range of proteins, including his-
tones, transcription factors, membrane proteins, and RNA-binding proteins (RBPs) (Yang and Bedford,
2013). In mammalian cells, 10 protein arginine methyltransferases (PRMTs) are responsible for arginine
methylation and have been classified into three groups according to their catalytic machinery (Yang and
Bedford, 2013; Hatanaka et al., 2017). PRMT1, PRMT2, PRMT3, PRMT4 (also called CARM1), PRMT6,
PRMT8, and METTL23 belong to type I PRMTs, which catalyze the formation of mono-methylarginine
and asymmetric dimethylarginine. PRMT5 and PRMT9 are known as type II PRMTs, which are capable of
producing mono-methylarginine and symmetric dimethylarginine (Hadjikyriacou et al., 2015; Yang et al.,
2015). PRMT7 has been characterized as a type III enzyme synthesizing only mono-methylarginine (Zur-
ita-Lopez et al., 2012).
PRMT1, a ubiquitously expressed type I enzyme, was the first identified PRMT, and it regulates a wide va-
riety of cellular processes, such as transcription, DNA damage response, and signal transduction (Wang
et al., 2001; Yamagata et al., 2008; Yang and Bedford, 2013). The in vivo functions of PRMT1 were not iden-
tified in mammals for a long time, because conventional PRMT1-deficient mice showed early embryonic
lethality (Pawlak et al., 2000). In recent years, two independent reports using heterozygous Prmt1-deficient
mice revealed that PRMT1 controls hepatic gluconeogenesis and neuronal excitability in the CNS (Choi
et al., 2012; Kim et al., 2016). Another group reported that lack of PRMT1 in murine muscle stem cells im-
pairs muscle regeneration (Blanc et al., 2017). On the other hand, we demonstrated that CNS-specific
PRMT1-deficient mice exhibited hypomyelination, indicating a vital role of PRMT1 in oligodendrocyte
development (Hashimoto et al., 2016). Furthermore, we also showed that loss of PRMT1 in vascular endo-
thelial cells results in angiodysplasia in mouse embryo (Ishimaru et al., 2017). Thus, an increasing number of
studies indicate that PRMT1 has crucial roles in multiple tissue functions and development.
Several reports have investigated the protein expression levels of PRMTs in the rodent heart and show that
the cardiac tissue expresses PRMT1, PRMT3, PRMT4, PRMT5, and PRMT7 (Bulau et al., 2007). In addition,
PRMT5 directly methylates GATA4 transcription factor, and inhibits phenylephrine-induced cardiomyocyte
hypertrophy in neonatal rat ventricular myocytes (Chen et al., 2014). PRMT4 has been shown to regulate
aging-related autophagy in mouse heart (Li et al., 2017). Interestingly, cardiac PRMT1 expression is200 iScience 8, 200–213, October 26, 2018 ª 2018 The Author(s).
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increased in patients with coronary artery disease and in rats with isoproterenol-induced heart failure (Chen
et al., 2006; Li et al., 2012), suggesting the importance of PRMT1 in the heart. However, the physiological
function of PRMT1 in the heart remains to be elucidated.
A number of reports have demonstrated that genetic deletion of RBP causes abnormal alternative splicing,
resulting in lethal heart failure (Xu et al., 2005; Guo et al., 2012; Ye et al., 2015; Wei et al., 2015). SRSF1, a
serine/arginine-rich family of splicing factors, is essential for the splicing switch of the Ca2+/calmodulin-
dependent kinase II d (Camk2d) gene, and its deficiency in mouse cardiomyocytes leads to dilated cardio-
myopathy (DCM) (Xu et al., 2005). Moreover, mutations in RNA-binding motif protein 20 (RBM20) gene, a
regulator of titin (Ttn) mRNA splicing, has been shown to cause human DCM (Guo et al., 2012; Wells et al.,
2013; Beqqali et al., 2016). Other reports have shown that hnRNP U and RBFOX2 are necessary for alterna-
tive splicing of some genes andmaintenance of cardiac function inmousemodels (Ye et al., 2015;Wei et al.,
2015). Interestingly, using a proteomic approach, it has been shown that many types of RBPs, such as SRSFs,
RBMs, hnRNPs, and RBFOXs, are methylated in the arginine residues (Guo et al., 2014). Although it has
been reported that PRMT1 methylates various RBPs, including hnRNP A2, hnRNP U, and RBM15 (Nichols
et al., 2000; Herrmann et al., 2004; Zhang et al., 2015), there is no in vivo evidence that PRMT1 regulates
alternative splicing.
In this study, we aimed to assess whether the deletion of PRMT1 affects cardiac functions and alternative
splicing events in the heart. To this end, we generated cardiomyocyte-specific PRMT1-deficient mice and
found that they display features of heart failure, including contractile dysfunction and cardiac chamber dila-
tion. Furthermore, we also found that the deletion of PRMT1 impairs alternative splicing of mRNA in the
heart and detected uncharacterized alternative splicing isoforms in some genes. Finally, we demonstrated
that protein products translated from alternatively spliced mRNA variants exhibit distinct ubiquitination
status in C2C12 myoblast cells. Our results clarify the essential role of PRMT1 in cardiac homeostasis
and alternative splicing.
RESULTS
PRMT1 Is Expressed in Both Cardiomyocytes and Non-myocytes
To elucidate the role of PRMT1 in the heart, we first examined the type of cells expressing PRMT1 using
Prmt1tm1a (EUCOMM) Wtsi knockin (PRMT1KI) mice (Skarnes et al., 2011). Prmt1tm1a (EUCOMM) Wtsi allele contains
FRT-flanked lacZ/neomycin sequence within intron 3 in Prmt1 gene. As PRMT1KI mice express b-galactosi-
dase (b-gal) driven by endogenous Prmt1 promoter, we performed X-gal staining using hearts from em-
bryos and adult mice. At embryonic day 19, b-gal activity was ubiquitously detected in the heart section,
including atrial and ventricular walls (Figure 1A). In the adult mice, b-gal activity was found in the center
of cardiomyocytes and in the vascular wall cells (Figure 1B). To further investigate PRMT1-expressing cell
types, we examined the protein expression levels of PRMT1 in isolated primary cardiomyocytes and
non-myocytes from cardiac tissues of C57BL/6 mice. Consistent with the results of X-gal staining, PRMT1
was expressed in cardiomyocytes and non-myocytes in the mouse heart (Figure 1C).
Cardiomyocyte-Specific PRMT1 Deletion Causes Dilated Cardiomyopathy in Juvenile Mice
To examine the function of PRMT1 in cardiomyocytes, we generated cardiomyocyte-specific PRMT1-defi-
cient (hereafter referred to as PRMT1-cKO) mice. These mice were obtained by crossing Prmt1flox/flox mice
with a myosin heavy chain (aMHC)-Cre transgenic mice (Figures 1D and 1E). PRMT1 protein levels were
decreased in the heart of PRMT1-cKO mice compared with Prmt1flox/flox (control) mice (Figure 1F). Immu-
nohistochemical analysis revealed that PRMT1 is mainly expressed in the nuclei of cardiomyocytes and
non-myocytes in control mice (Figure 1G, upper panels). Furthermore, in both control and cKO mice,
non-myocytes showed various levels of green fluorescence, suggesting that PRMT1 expression levels
are highly heterogeneous among non-myocytes depending on the cell types (Figure 1G, arrows). We found
that the signals of PRMT1 were dramatically reduced in the cardiomyocytes of PRMT1-cKO mice, whereas
non-myocytes normally expressed PRMT1 (Figure 1G, lower panels). These data clearly show that PRMT1 is
specifically deleted in the cardiomyocytes of PRMT1-cKO mice.
To determine the influence of PRMT1 deletion on the heart, we analyzed the cardiac morphology and func-
tion in PRMT1-cKO mice. Although PRMT1-cKO mice were born in a normal Mendelian ratio (data not
shown), they died within 60 days of birth (Figure 2A). Heart weight and heart/body weight ratio were
significantly increased in 6-week-old PRMT1-cKO mice compared with age-matched control and Prmt1iScience 8, 200–213, October 26, 2018 201
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Figure 1. Generation of Cardiomyocyte-Specific PRMT1-Deficient Mice
(A and B) X-gal staining of (A) fetal and (B) adult hearts in PRMT1KI mice. The asterisk indicates cardiac artery.
(C) Western blotting of PRMT1 in neonatal mouse cardiomyocytes (CM) and non-myocytes (NM). Cardiac troponin I (cTnI)
and vimentin were used as specific markers for CM and NM, respectively. GAPDH was used as loading control.
(D) Schematic diagram of Prmt1 gene targeting. Black rectangles indicate exons of Prmt1, and blue allows show primer
set for genotyping.
(E) Representative images of genotyping in PRMT1-cKO mice.
(F) Western blotting analysis of PRMT1 in the hearts of control (ff/-) and PRMT1-cKO (ff/cre) mice. The hearts were
harvested from 2-, 4-, and 6-week-old (shown as 2w, 4w, and 6w in the figure) mice.
(G) Representative images of cardiac sections stained with anti-PRMT1 antibody (green), Hoechst 33258 (blue), anti-
cardiac troponin I antibody (magenta), and WGA (gray). Arrowheads indicate nuclei of cardiomyocytes. Arrows indicate
non-cardiomyocytes.hetero-deficient mice (Figures 2B and 2C). PRMT1-cKO mice exhibited marked cardiac chamber dilation
and fibrosis at 6 weeks of age (Figure 2D, lower panels). Cardiac systolic function of PRMT1-cKO mice
began to reduce within 4 weeks after birth, and further reduction was observed in 6-week-old mice (Fig-
ure 2E). Furthermore, expression levels of bMHC (Myh7), ANP (Nppa), and BNP (Nppb) genes, which are202 iScience 8, 200–213, October 26, 2018
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Figure 2. Dilated Cardiomyopathy of PRMT1-cKO Mice
(A) Survival rate of control, heterozygous (fw/cre), and PRMT1-cKO mice.
(B and C) (B) Heart weight and (C) heart weight/body weight ratio (HW/BW) of 2-, 4-, and 6-week-old mice (n = 4–6).
(D) H&E and Masson’s trichrome (MT) staining of the hearts at different ages.
(E) Cardiac contractility of control and PRMT1-cKO mice at different ages.
(F) Gene expression analysis for marker genes of cardiac dysfunction in the heart of 4-week-old control and PRMT1-cKO
mice (n = 4).
All data are presented as mean G SEM. *p < 0.05, **p < 0.01, ***p < 0.001 compared with age-matched control mice.well-characterized markers of heart failure, were significantly elevated in the heart of PRMT1-cKO mice
at 4 weeks of age (Figure 2F).
We further conducted a comprehensive analysis of gene expression changes in the heart of 6-week-old
PRMT1-cKO mice using RNA sequencing (RNA-seq). Gene expression analysis identified 2,037 differen-
tially expressed genes between control and PRMT1-cKO mice: 1,044 genes were upregulated and 993
genes were downregulated (Table S1, Figures S1A and S1B). Consistent with the results of histological
analysis, fibrosis-related genes, such as Tgfb2, Ctgf, and collagen family, were induced in the heart of
PRMT1-cKO mice (Table S1). On the other hand, Kyoto Encyclopedia of Genes and Genomics pathway
analysis of decreased genes showed an enrichment in pathways related to energy metabolism, mitochon-
drial function, and DCM (Figure S1C). This transcriptional profile of the PRMT1-cKO mice coincides with
that of a DCM mouse model carrying a missense mutation in the phospholamban gene (Burke et al.,
2016). These observations clearly demonstrated that juvenile PRMT1-cKO mice develop lethal DCM and
that PRMT1 plays critical roles in maintaining cardiac homeostasis.
Cardiomyocyte-Specific Loss of PRMT1 Causes Aberrant Alternative Splicing of mRNA in the
Heart
To examine the effect of PRMT1 deletion on cardiac alternative splicing, we focused on the known alter-
native splicing events that are observed in the loss of function or the gain of function in animal modelsiScience 8, 200–213, October 26, 2018 203
for RBPs in the heart (Table S2), and analyzed RNA-seq data. Sashimi plots revealed differences in
exon usage of several genes between control and PRMT1-cKO mice at 6 weeks of age (Figure 3A).
These results were confirmed by RT-PCR using the heart of 4-week-old mice, indicating that alternative
splicing abnormality occurs in the early stage of cardiac pathogenesis in PRMT1-cKO mice (Figures 3B
and 3C).
Alternative splicing defects or mutations of Ttn gene, which encodes a giant sarcomeric protein, are closely
associated with DCM (Guo et al., 2012; Herman et al., 2012; Schafer et al., 2017). Consistent with a previous
work using rat model (Li et al., 2013), intron retention was observed within the regions encoding middle Ig
domains and PEVK regions in the heart of control mice, whereas it was clearly reduced in those of PRMT1-
cKO mice aged 6 weeks (Figures 3D and 3E). Similar changes in alternative splicing of Ttn gene have been
found in RBM20 knockout rats and cardiomyocyte-specific hnRNP U-deficient mice (Guo et al., 2012; Li
et al., 2013; Ye et al., 2015). These results indicate that PRMT1 modulates cardiac alternative splicing
events, regulated by a wide-range of RBPs.The Heart of PRMT1-cKO Mouse Provides Valuable Tissues for Exploration of Unidentified
Alternative Splicing Events
To further investigate the effects of PRMT1 deletion on alternative splicing in the heart, we searched for the
genes that display abnormal splicing pattern in PRMT1-cKOmice. From RNA-seq data, we extracted genes
that have differences in expression levels of splicing isoform between control and PRMT1-cKO mice and
found 74 candidate genes (Table S3). A gene ontology analysis of the 74 candidates showed enrichment
of genes implicated in muscle development, such as muscle cell development, myofibril assembly, and
actin cytoskeleton organization (Figure S2). This hallmark was similar to that of some RBP-deficient animals
(Guo et al., 2012; Wei et al., 2015; Dixon et al., 2015). Among the 74 genes, the alternative splicing of Ttn,
Lmo7, Tnnt2, Rtn4, andObscn has been shown to be directly regulated by RBM20 (Maatz et al., 2014). The
alterations in Pdlim5 and Ldb3 splicing have been observed in RBM20-, RBFOX2-, and MBNL1-deficient
animals (Guo et al., 2012; Wei et al., 2015; Dixon et al., 2015). In addition, alternative splicing events of
Pkm, Sptan1, Ppfibp1, and Popdc2 genes in the heart have already been reported (Gao and Cooper,
2013; Cianci et al., 1999; Kalsotra et al., 2008). Thus, these results led us to believe that our screening pro-
tocol was sensitive enough to pick up other unknown splicing events that occur in the pathologic hearts.
Next, we validated those new alternative splicing events that have not been characterized in mouse hearts
to date.
ASB2, a component of ECS-type (ElonginBC-Cullin-SOCS box) E3 ligase complex, has been shown to be
essential for the cardiomyocyte maturation in zebrafish model (Fukuda et al., 2017). In the heart of PRMT1-
cKO mice, a large number of reads were detected following Asb2 exon 6 compared with control mice,
indicating the existence of the extended form of exon 6 (Figure 4A). This extended exon 6 has not been
registered in the NCBI, Ensembl, or UCSC database. To verify the presence of the novel isoform of exon
6, we designed a primer set for the detection of the extended exon 6 and performed RT-PCR analysis.
Although the expression level of the known transcript that includes exons 6 and 7 was slightly but signifi-
cantly decreased in PRMT1-cKOmice, the extended exon 6 expression was increased in PRMT1-cKO hearts
(Figures 4B and 4C). Because the extended exon 6 contains a stop codon and a putative poly(A) signal, this
exon may serve as a composite terminal exon (Figure S3A; Tian and Manley, 2013). This suggests that this
novel transcript encodes truncated ASB2 protein lacking SOCS box, which is required for the formation of
E3 ligase complex (Figure S3A; Okumura et al., 2012).
FBXO40 is a component of SCF (Skp, Cullin, and F box) E3 ligase complex, modulating insulin-like
growth factor 1 (IGF1) receptor signaling pathway via ubiquitination of IRS1 in skeletal muscle (Shi
et al., 2011). A large part of FBXO40 coding sequence is encoded by exon 3 (Ensembl Transcript ID:
ENSMUST00000075869.12). Although most of the Fbxo40 mRNA was contained in exon 3 in the control
hearts, exon 3 skipping was significantly increased in the PRMT1-cKO hearts (Figures 4A–4C).
Nrap (nebulin-related anchoring protein) gene encodes a cytoskeletal protein (Bang and Chen, 2015). It has
been reported that the expression of NRAP is upregulated in mouse models of DCM (Ehler et al., 2001).
Furthermore, several studies investigated the alternative splicing ofNrap exon 12 included in skeletal mus-
cle isoform, but not in cardiac isoform (Mohiddin et al., 2003; Berger et al., 2011). In addition to exon 12, the
NCBI database suggests thatNrap exon 2 is alternatively spliced (NM_001286552.1); however, this splicing204 iScience 8, 200–213, October 26, 2018
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Figure 3. Aberrant Alternative Splicing in the Heart of PRMT1-cKO Mice
(A) Representative images of Sashimi plot depicting alternative splicing pattern in the heart of 6-week-old mice. Read counts for each sample are indicated
on the y axis.
(B and C) (B) Gel images of RT-PCR products and (C) percent spliced in (PSI) value calculated from the band intensities for assessing changes in alternative
splicing in the heart of 4-week-old mice (n = 4).
(D) Representative images of Sashimi plot depicting alternative splicing of Titin (Ttn) gene in the heart of 6-week-old mice. Read counts for each sample are
indicated on the y axis.
(E) Gel images of RT-PCR products for Titin gene. Blue rectangles and red lines indicate exons and introns of Titin gene, respectively.
All data are presented as mean G SEM. **p < 0.01, ***p < 0.001 compared with control mice.
iScience 8, 200–213, October 26, 2018 205
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Figure 4. Novel Alternative Splicing Events in the Heart
(A) Representative Sashimi plots depicting alternative splicing pattern in the heart of 6-week-old mice. Read counts for
each sample are indicated on the y axis.
(B and C) (B) Gel images of RT-PCR products and (C) relative expression (for Asb2) or PSI value (for Fbxo40, Nrap, and
Eif4a2) calculated from the band intensities in the heart of 4-week-old mice (n = 4).
All data are presented as mean G SEM. **p < 0.01, ***p < 0.001 compared with control mice.event has not been characterized in the heart. Although alternative splicing defect ofNrap has been found
in the heart of Rbfox2-KOmice, a model of DCM, which exons are affected by Rbfox2 deficiency in the heart
has not been addressed (Wei et al., 2015). We found that exon skipping of Nrap exon 2, encoding an LIM
domain of NRAP protein, was significantly increased in PRMT1-cKO mice (Figures 4A–4C).
Eif4a2 gene encodes eIF4A2 DEAD-box RNA helicase associated with translation initiation, microRNA-
mediated gene repression, and stress granule formation (Meijer et al., 2013; Jongjitwimol et al., 2016).
A previous report demonstrated that knockdown of splicing factor U2AF65 or U2AF35 induces the inclusion
of a 107-nucleotide (nt) exon of EIF4A2 in HeLa cells (Shao et al., 2014). Importantly, the exon-intron struc-
ture of eIF4A2 gene is highly conserved between human and mouse (Figure S3B, a–c). In the PRMT1-cKO
mice, the 107-nt exon inclusion of Eif4a2 was significantly increased compared with control mice (Figures
4A–4C).
Taken together, we discovered previously unrecognized cardiac alternative splicing events through the use
of PRMT1-cKO mice.206 iScience 8, 200–213, October 26, 2018
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Figure 5. Differential Ubiquitination Status of eIF4A2 Isoforms
(A) RT-PCR analysis for detecting Eif4a2 alternative splicing in undifferentiated and differentiated C2C12 cells.
(B) Schematic diagrams of Eif4a2 pre-mRNA 30 end, C-terminal sequences of eIF4A2, and eIF4A2 protein domains.
(C) Western blot analysis of HA-eIF4A2 wild-type (wt) and truncated (tr) isoforms in C2C12 cells 24 hr after transfection. b-Actin was used as a loading control.
(D) Immunoprecipitation assay for detecting ubiquitination of HA-eIF4A2 isoforms in C2C12 cells. At 16 hr after transfection, cells were treated with MG132
(10 mM) for 8 hr.eIF4A2 Isoforms Are Differentially Ubiquitinated and Degraded in C2C12 Cells
Finally, we explored the significance of alternative splicing of Eif4a2 under more physiological conditions. It
has been reported that Eif4a2 mRNA expression is increased in differentiating C2C12 mouse myoblast
cells, and that double knockdown of Eif4a1 and Eif4a2 suppresses myoblast differentiation into myotubes
(Galicia-Vazquez et al., 2014). The differentiation process of C2C12 cells is intimately involved in alternative
splicing (Bland et al., 2010; Singh et al., 2014), whereas the association between alternative splicing of
Eif4a2 and C2C12 differentiation is undefined. Therefore, we investigated whether C2C12 differentiation
is linked to alternative splicing change of Eif4a2. We found that the undifferentiated C2C12 cells predom-
inantly expressed long Eif4a2 transcripts (Figure 5A). Furthermore, the long Eif4a2 isoform expression was
reduced in differentiating C2C12 cells, whereas that of the short Eif4a2 isoform was markedly increased
(Figure 5A). Although changes in alternative splicing of Eif4a2 were found in PRMT1-deficient hearts (Fig-
ure 4) and U2AF knockdown cells (Shao et al., 2014), data suggested that these splicing changes were also
induced by physiological stimuli, such as myoblast differentiation.
The NCBI database predicts that the long Eif4a2 transcript (NR_110335.1), upregulated in the heart of
PRMT1-cKO mice (Figure 4), is a candidate for nonsense-mediated mRNA decay (NMD). Indeed, the
107-nt exon of long Eif4a2 transcript contains a premature termination codon (PTC) positioned more
than 50–55 nt upstream of the last exon-exon junction (Figure 5B). However, several reports haveiScience 8, 200–213, October 26, 2018 207
demonstrated that the PTC-containing transcript escapes NMD, and is translated into a truncated protein
that plays an important physiological role (Holbrook et al., 2004; Bamber et al., 1999; Donnadieu et al.,
2003). Furthermore, our data showed that PTC-containing long Eif4a2 transcript is expressed at substantial
levels in the heart of PRMT1-cKOmice and in undifferentiated C2C12 cells (Figures 4B and 5A), suggesting
that long Eif4a2 transcript is translated into truncated eIF4A2 protein (Figure 5B). Although eIF4A2 pos-
sesses motif VI, which probably functions as a trigger of ATP hydrolysis, at its C terminus (Pause and Sonen-
berg, 1992; Schutz et al., 2008), truncated eIF4A2 isoform partially lacks motif VI (Figure 5B).
To investigate the functional difference of eIF4A2 isoforms, expressed differentially in the heart of control
and PRMT1-cKO mice, we generated hemagglutinin (HA)-tagged eIF4A2 (HA-eIF4A2-wt) and HA-tagged
truncated-eIF4A2 (HA-eIF4A2-tr) expression vectors. Although equivalent amount of vectors was trans-
fected into C2C12 cells, unexpectedly, the protein level of HA-eIF4A2-tr was remarkably lower than that
of HA-eIF4A2-wt (Figure 5C). A previous study showed that eIF4A2 protein is sumoylated on K226 in
mammalian cells (Jongjitwimol et al., 2016), whereas some proteomic analyses indicated that eIF4A2 pro-
tein contains several ubiquitination sites (Danielsen et al., 2011, Kim et al., 2011; curated information is
available on PhosphoSitePlus, a database of post-translational modifications). Therefore, we hypothesized
that HA-eIF4A2-tr protein is ubiquitinated and degraded by the ubiquitin-proteasome system. To examine
this hypothesis, we treated C2C12 cells with MG132 after transfection and assessed the ubiquitination
levels of HA-eIF4A2 isoforms. MG132 treatment increased both HA-eIF4A2-wt and HA-eIF4A2-tr protein
levels (Figure 5D, input). Furthermore, poly-ubiquitination of HA-eIF4A2-wt and HA-eIF4A2-tr was de-
tected in MG132-treated C2C12 cells (Figure 5D, immunoprecipitation [IP]: HA). It is noteworthy that
HA-eIF4A2-tr protein was highly ubiquitinated compared with HA-eIF4A2-wt (Figure 5D, IP: HA), indicating
that the 47 amino acid residues in the C terminus of eIF4A2-wt protect against ubiquitination and subse-
quent degradation by the ubiquitin-proteasome system.
DISCUSSION
In the present study, we generated cardiomyocyte-specific PRMT1-deficient mice and demonstrated the
vital role of PRMT1 in maintaining cardiac function. Moreover, cardiac alternative splicing was disturbed
in the heart of PRMT1-cKO mice, indicating the critical role of PRMT1 in the regulation of alternative
splicing in vivo. In addition, using this animal model, we successfully detected novel alternative splicing
products in the heart.
PRMT1 Is Essential for Cardiac Development in Mice
Accumulating evidence demonstrates that PRMT1, a dominant type I PRMT in mammalian cells, controls
tissue development, regeneration, and homeostasis in vivo (Hashimoto et al., 2016; Blanc et al., 2017). In
the present study, we showed that cardiomyocyte-specific deletion of PRMT1 provoked DCM in juvenile
mice. Although PRMT1 has been suggested to be involved in the pathogenesis of heart diseases via over-
production of free asymmetric dimethylarginine followed by its nitric oxide synthase (NOS)-inhibiting effect
(Haghikia et al., 2011; Li et al., 2012), our data clearly demonstrated that PRMT1 has essential roles in cardiac
development and homeostasis under physiological conditions. Despite the parallel expression of PRMT1 in
cardiomyocytes and non-myocytes, PRMT1 deficiency in cardiomyocytes led to DCM in juvenile mice,
demonstrating an indispensable role of arginine methylation catalyzed by PRMT1 in cardiomyocytes.
Association between PRMT1 and Cardiac Splicing Regulation
In the postnatal heart, many physiological and structural changes occur, becoming fully functional by adult-
hood. Although these processes are transcriptionally regulated, alternative splicing also participates in
postnatal cardiac development (Baralle and Giudice, 2017). Interestingly, it has been demonstrated that
the majority of alternative splicing transitions in cardiomyocytes occur during the first 4 weeks after birth
in mice (Giudice et al., 2014). In the present study, we found that PRMT1-cKO mice showed cardiac alter-
native splicing defects and reduction of cardiac contractility at 4 weeks after birth. We therefore postulated
that alternative splicing transition fails in PRMT1-cKO mice. Indeed, we showed that exon skipping of
Tmed2 and Snap23 was significantly increased in 4-week-old PRMT1-cKO mice (Figures 3B and 3C); these
splicing patterns resemble the feature in neonatal hearts (Giudice et al., 2014). These observations suggest
that PRMT1 regulates alternative splicing transition in the postnatal hearts.
In this study, we found and validated the four novel splicing events in the heart (Figure 4). Among these, we
discovered a new Asb2 isoform that is not registered in the NCBI, Ensemble, or UCSC database. This novel208 iScience 8, 200–213, October 26, 2018
Asb2 transcript, which has the extended exon 6 containing a stop codon and a putative poly(A) signal,
seems to encode truncated ASB2 protein that lacks SOCS box, suggesting the failure to form E3 ligase
complex. On the other hand, ankyrin repeat, a putative substrate recognition motif (Li et al., 2006; Andre-
sen et al., 2014), partially remained in truncated ASB2 protein. Therefore, this truncated ASB2 might
function as a dominant-negative isoform to trap substrates. To detect the truncated ASB2 protein, we
used commercially available anti-ASB2 antibody that is raised against the N-terminal of ASB2. We were
unable to confirm the expression of truncated ASB2 protein in cardiac lysate, whereas weak signal from
the full-length ASB2 protein was seen (data not shown), probably because of a lower expression level of
truncated ASB2 than full-length protein. Since the expression level of novel Asb2 isoform was increased
in the PRMT1-deficient hearts, PRMT1 may be involved in determining alternative polyadenylation sites
in the cardiomyocytes.
Although splicing events of three other genes (Fbxo40,Nrap, and Eif4a2) are recorded in at least one data-
base, there is no evidence demonstrating that these splicing events actually occur in the hearts. It has been
reported that FBXO40, a component of SCF E3 ligase complex, regulates IGF1 signaling in the skeletal
muscle (Shi et al., 2011). FBXO40 is also expressed in human and rodent hearts (Ye et al., 2007), but its func-
tion remains unclear. We found that skipping of the exon encoding a large part of FBXO40 protein was
significantly increased in the PRMT1-cKO heart (Figures 4B and 4C). The Ensembl database predicts that
this transcript does not contain an open reading frame, suggesting that this short form of Fbxo40 transcript
exists as long non-coding RNA (lncRNA). Interestingly, a recent study revealed that lncRNA, which is pro-
duced by alternative splicing of protein-coding gene, plays an important role in tumor progression (Grelet
et al., 2017). This raises the possibility that lnc-Fbxo40 has pathophysiological roles in the heart, and PRMT1
acts as a molecular switch to regulate Fbxo40 gene function. However, further studies are needed to
confirm whether the short form of Fbxo40 transcript functions as an lncRNA.
We showed that the usage ofNrap exon 2 was significantly decreased in the heart of PRMT1-cKOmice (Fig-
ures 4B and 4C). Nrap transcript that lacks exon 2 encodes an NRAP protein deficient for the LIM domain.
NRAP is dominantly expressed in cardiac and skeletal muscles, and is upregulated in the heart of DCM
mouse models (Bang and Chen, 2015). NRAP is localized in Z-disk precursors during myofibrillogenesis,
whereas specific localization of NRAP at the intercalated disks is found in the adult heart (Bang and
Chen, 2015). A previous report revealed that the LIM domain of NRAP strongly binds to talin: talin binds
the cytoplasmic domain of b1D integrin subunit, whereas NRAP super-repeats bind to actin, suggesting
that NRAP is a component of the protein complex that anchors actin filaments to the plasma membrane
(Luo et al., 1999). Although integrin and talin are mainly localized in the costamere, they are also found
at the intercalated disks in the heart (Israeli-Rosenberg et al., 2014; Manso et al., 2013). Interestingly, a
recent study demonstrated that talin1/talin2 double knockoutmice exhibit DCM (Manso et al., 2017). These
observations suggest that increase in NRAP lacking the LIM domain may affect the mechanotransduction
system through the absence of binding to integrin and talin in the intercalated disks and may contribute to
cardiac pathogenesis. Because the role of integrin system in the intercalated disks is largely unknown, it is
interesting to investigate the implication inNrap isoform shift and the function of NRAP lacking LIM domain
in the heart.
It has been shown that knockdown of splicing factor U2AF increases the 107-nt exon inclusion of EIF4A2 in
HeLa cells (Shao et al., 2014). In the present study, we found that this 107-nt exon of mouse Eif4a2 is alter-
natively spliced in the heart and C2C12 cells, suggesting that alternative splicing of Eif4a2 occurs under
physiological conditions in the cardiac and skeletal muscle cells. We assumed that long Eif4a2 transcript
encodes truncated eIF4A2 protein and examined its protein function. Unexpectedly, we found that the
eIF4A2 protein is constantly ubiquitinated, and that the truncated isoform is more efficiently ubiquitinated
and degraded than the eIF4A2-wt protein, indicating that the splicing switch of Eif4a2may regulate its pro-
tein levels utilizing the ubiquitin-proteasome system. It has been reported that eIF4A is overexpressed in
lung and cervical cancer, and inhibitors of eIF4A have antitumor activity (Bhat et al., 2015). Therefore, an
understanding of the molecular basis for alternative splicing and ubiquitination of eIF4A2 may provide
new insight into the pathogenesis of heart failure, muscle differentiation, and cancer therapy.PRMT1 Is a Possible Upstream Regulator of RBPs
In the past decade, a number of studies have revealed the critical roles of the RBPs in the cardiac alternative
splicing regulation by analyzing genetically engineered mice. On the other hand, we showed that deletioniScience 8, 200–213, October 26, 2018 209
of PRMT1 impairs the cardiac alternative splicing of a broad spectrum of genes, including already reported
genes that are affected by the deletion or mutation of RBPs. These observations raise the possibility that
PRMT1 participates in alternative splicing regulation through the methylation of RBPs in the cardiomyo-
cytes. It has been reported that cardiomyocyte-specific deletion of hnRNP U (also known as SAF-A)
results in splicing defects and severe DCM (Ye et al., 2015). Importantly, a previous report demonstrated
that PRMT1 methylates hnRNP U, whereas arginine methylation of hnRNP U did not affect its nuclear
localization (Herrmann et al., 2004). SRSF1 (as known as SF2/ASF) deficiency in cardiomyocytes also
contributes to aberrant splicing and DCM (Xu et al., 2005). Although which PRMTs are involved is unknown,
arginine methylation controls SRSF1 nuclear localization (Sinha et al., 2010). Furthermore, proteomic
analyses suggested that other RBPs that are related to the cardiac alternative splicing, such as RBFOX1,
RBFOX2, MBNL1, and SRSF10, have putative arginine methylation sites (Guo et al., 2014; Larsen et al.,
2016; Geoghegan et al., 2015). Our results suggest that PRMT1 may serve as a key regulator of RBPs
functions, such as nuclear localization, RNA-binding properties, and binding of other splicing factors, in
the cardiomyocytes.
Taken together, our findings identify an essential role of PRMT1 in the cardiac alternative splicing in vivo,
and the heart of PRMT1-cKO mouse is an effective tool for understanding the relationship between alter-
native splicing regulation and heart failure.
Limitations of the Study
In the present study, we showed that PRMT1 deficiency in cardiomyocytes causes aberrant alternative
splicing in the heart. As it is currently not known whether the changes in alternative splicing are due to
direct effects of PRMT1 deficiency or secondary consequences (e.g., an influence of DCM), we examined
the effect of PRMT1 knockdown on alternative splicing of Eif4a2 in C2C12 cells. However, we were unable
to accurately assess the contribution of PRMT1 to Eif4a2 splicing in undifferentiated or differentiated
C2C12 cells (data not shown). This may be because knockdown of PRMT1 was inefficient for changing
Eif4a2 alternative splicing, or PRMT1 regulates alternative splicing in a cell-type-dependent manner.
Therefore, other experimental models are needed to investigate whether the changes in alternative
splicing are due to the lack of PRMT1.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
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Figure S1 (related to Figure 3). Gene expression profile of RNA-Seq data 
(A and B) A hierarchical clustering and a volcano plot based on the 2,037 differentially 
expressed genes between control and PRMT1-cKO group (adjusted FDR P value < 0.05). (C) 
Functional enrichment analysis of 993 downregulated genes in PRMT1-cKO mice. The top 20 
enriched pathways are shown in the table. A list of matched genes with DCM-related gene sets 
in the box insert. See also Table S1. 
 
 
Figure S2 (related to Figure 4). Gene ontology (GO) analysis of alternatively expressed 
isoforms between control and PRMT1-cKO mice  
GO analysis of 74 genes was performed using the PANTHER web tool (Mi et al., 2013). The 
top 10 enriched GO terms are shown in the graph. 
 
Figure S3 (related to Figure 4). Schematic diagrams of Asb2 mRNA/protein and Eif4a2 
gene 
(A) 3' side of Asb2 mRNA and domain structure of ASB2 protein. The extended exon 6 
contains a stop codon and a putative poly(A) signal. (B) Structures of human and mouse Eif4a2 
transcripts. (a-c) DNA sequences surrounding splice donor and acceptor sites.  
 
Table S2 (related to Figure 3). Summary of known cardiac alternative splicing events that 
were investigated as illustrated in Figure 3. 
 
Table S3 (related to Figure 4). Candidate genes exhibiting aberrant alternative splicing in 
PRMT1-cKO mice. 
Transparent Methods 
 
Animal experiments 
PRMT1KI mice that carry Prmt1tm1a(EUCOMM)Wtsi allele and Prmt1flox/flox mice were obtained and 
generated as previously described (Hashimoto et al., 2016). To create PRMT1-cKO mice, 
Prmt1flox/flox mice were mated with αMHC-cre transgenic mice (strain name: 
B6.FVB-Tg(Myh6-cre)2182Mds/J, stock number: 011038, The Jackson Laboratory). C57BL/6J 
mice were purchased from CLEA Japan for isolation of primary cardiomyocytes and 
non-myocytes. Genotype of PRMT1-cKO mice was determined by PCR and agarose gel 
electrophoresis. Briefly, a small piece of tail was removed from 10-14-day-old mice, and direct 
PCR was performed using HelixAmp Direct PCR 3G (NanoHelix #DPR200) in accordance 
with the manufacturer’s instructions. The primer sequences were as follows: Prmt1 
(5'-GTGCTTGCCATACAAGAGATCC-3' and 5'-GTGAAACATGGAGTTGCGGTAT-3'); 
αMHC-cre transgene (5'-ATGACAGACAGATCCCTCCTATCTCC-3' and 
5'-CTCATCACTCGTTGCATCATCGAC-3'). To assess cardiac contractile function, 
echocardiography was performed as described previously (Murata et al., 2013). Male mice were 
used for all experiments except X-gal staining. 
   All animal experiments were performed in a humane manner and approved by the 
Institutional Animal Experiment Committee of the University of Tsukuba. Experiments were 
conducted in accordance with the Regulations for Animal Experiments of the University of 
Tsukuba and the Fundamental Guidelines for Proper Conduct of Animal Experiments and 
Related Activities in Academic Research Institutions under the jurisdiction of the Ministry of 
Education, Culture, Sports, Science and Technology of Japan. 
 
Histological analysis 
Hearts were embedded in paraffin and sectioned as previously described (Murata et al., 2013). 
Deparaffinized cardiac sections (5 and 3 µm thick) were stained with hematoxylin-eosin (HE) 
and Masson’s trichrome reagents. Images were obtained using a BX53 microscope and DP21 
digital camera (Olympus).  
   For immunohistochemistry, deparaffinized cardiac sections (5 µm thick) were placed in 10 
mM sodium citrate buffer (pH 6.0), boiled 20 seconds in a microwave oven, and cooled at room 
temperature for 20 minutes. To inactivate endogenous peroxidase, sections were incubated with 
3% H2O2 for 30 minutes. After incubation with TSA blocking reagent (Perkin Elmer, #FP1020) 
for 30 minutes, sections were incubated with anti-PRMT1 antibody (1:200, rabbit-monoclonal, 
abcam, #ab92299) at room temperature for 60 minutes. Sections were then reacted with 
biotinylated anti-rabbit antibody (1:500, Vector, #BA1000) for 30 minutes at room temperature. 
Secondary antibodies were detected using the tyramide signal amplification (TSA) Plus 
Fluorescein System (Perkin Elmer, #NEL756001KT). For double-staining, sections were 
incubated with anti-cardiac troponin I antibody (1:50, rabbit-polyclonal, abcam, #ab47003) for 
60 minutes at room temperature. Primary antibodies were visualized using Alexa Fluor 568 
conjugated secondary antibody (Thermo Fisher Scientific, A11011). CF640R conjugated wheat 
germ agglutinin (WGA, Biotium, #29026) and Hoechst 33258 were used to stain cellular 
membranes and nuclei. Fluorescent images were obtained using a FluoView FV10i confocal 
laser-scanning microscope (Olympus). 
 
X-gal staining 
For X-gal staining, 8-week-old mice were perfused with 4% paraformaldehyde (PFA), then the 
heart tissues were dissected, following immersion fixation in 4% PFA for 15 minutes. The 
hearts from E19 embryos were harvested and fixed with 4% PFA for 15 minutes. Tissues were 
then cryoprotected, embedded in O.C.T. compound, and cryostat sectioned. Sections were 
stained in 1xPBS containing 1 mg/ml X-gal, 5 mM K4Fe(CN)6/3H2O, 5 mM K3Fe(CN)6, 2 mM 
MgCl2, 0.05% sodium deoxycholate, and 0.02% NP-40 at 37˚C overnight. Slides were then 
counter-stained with eosin. Data images were obtained using a BX53 microscope and DP21 
digital camera (Olympus). 
 
Western blotting 
Immunoblot analysis was performed as previously described (Murata et al., 2016). The primary 
antibodies were as follows: anti-PRMT1 (1:500-1:1000, Millipore, #07-404), anti-cardiac 
troponin I (1:250, Santa Cruz Biotechnology, #sc-31655), anti-vimentin (1:1000, Cell Signaling 
Technology, #5741), anti-GAPDH (1:2000-1:10000, American Research Products, #05-50118). 
 
Cardiomyocyte isolation 
Ventricles harvested from neonatal mice were minced and enzymatically digested in HBSS 
(with Mg2+) containing 0.45 mg/ml collagenase type II (Worthington, #CLS2) and 0.11 mg/ml 
pancreatin (GIBCO, #002-0036DG) at 37ºC with gentle shaking and intermittent pipetting. Cell 
suspension was collected and filtered through a cell strainer (40 µm nylon mesh). The cells 
were collected by centrifugation, resuspended in cardiomyocyte (CM) growth medium 
(DMEM/M199 (4:1) with 10% horse serum (HYCLONE, #SH30074.03), 5% fetal bovine 
serum (FBS), 1.6 mM L-glutamine (Life Technologies, #25030-081), 80 µM non-essential 
amino acid (GIBCO, #11140-050), and penicillin-streptomycin (PS)), and plated on non-coated 
plastic dishes. After 2.5 hours incubation with 5% CO2 at 37ºC, the non-adhesive cells 
(cardiomyocytes) were collected, resuspended in CM growth medium containing 25 µM 
cytosine β-D-arabinofuranoside (Ara-C, SIGMA, #C1768), and plated on gelatin-coated dishes. 
The remaining adhesive cells (non-myocytes) were grown in DMEM supplemented with 10% 
FBS and PS. 
 
RNA experiments 
Cardiac RNA was extracted using mirVana miRNA Isolation Kit (Thermo Fisher Scientific, 
#AM1560) in accordance with the manufacturer's instructions. Large RNA fraction containing 
mRNA was used for gene expression assay. Reverse transcription and quantitative 
real-time-PCR was performed as described previously (Murata et al., 2013, Murata et al., 2016).  
   To validate alternative splicing events, RT-PCR was performed using AmpliTaq Gold DNA 
Polymerase (Thermo Fisher Scientific, #4398881) and PrimeSTAR Max DNA Polymerase (for 
detecting Fbxo40 isoforms, TAKARA, #R045A). PCR products were separated by 8.5% 
acrylamyde gel electrophoresis and stained with ethidium bromide. Images were acquired using 
an LAS-3000 imaging system (GE healthcare) and analyzed by ImageJ software (National 
Institutes of Health). Percent spliced in (PSI) value was calculated from the band intensity, as 
previously described (Giudice et al., 2014). The primers for RT-PCR were as follows:  
Tmed2-forward (5'-GTACACATTTGCAGCCCACA-3') 
Tmed2-reverse (5'-CTCCTGTTCGTGCTTTACGG-3') 
Snap23-forward (5'-GTGTTGTGGCCTCTGCATCT-3') 
Snap23-reverse (5'-TGGCTGCTCCTGTAGTTTGCT-3') 
Mef2a-forward (5'-AACTCAAGGGCCTCTCCAAA-3') 
Mef2a-reverse (5'-CACTACAGGCGTGGCAAGAG-3') 
Ktn1-forward (5'-GATCCATGAGAAAGATGGACAGA-3') 
Ktn1-reverse (5'-GCAGCTCCTGGACTTGAGAA-3') 
Lmo7-forward (5'-TGAGCCAAAGTCAGCTCTCC-3') 
Lmo7-reverse (5'-ACTTGCTCCCATTCTCACCA-3') 
Sorbs1-forward (5'-AGACCTTCGTCTGCCTACCC-3') 
Sorbs1-reverse (5'-GCATCCTTTGCCCTTCTCTC-3') 
Ttn (exon 47-48)-forward (5'-CCAGGCCGAGTTGACCATCA-3') 
Ttn (exon 47-48)-reverse (5'-GCAATGGAGGCGTGCTGATT-3') 
Ttn (exon 48-50)-forward (5'-CAGCACGCCTCCATTGCAAG-3') 
Ttn (exon 48-50)-reverse (5'-CAGGGATGGTCAAGACGGCA-3') 
Ttn (exon 132-134)-forward (5'-TCGGGAGGAGGAGTATGAGG-3') 
Ttn (exon 132-134)-reverse (5'-GGGTGGCAGAGGTTTGAGTT-3') 
Ttn (exon 147-150)-forward (5'-GCTCCCACTCCTGTCCCTAA-3') 
Ttn (exon 147-150)-reverse (5'-CACCCTGATGAACTCCTCCAC-3') 
Asb2 (exon 6-7)-forward (5'-CAGCATCACCCCTTTGTTTG-3') 
Asb2 (exon 6-7)-reverse (5'-TCATTCTTGCTGGCCTCGT-3') 
Asb2 (extended ex6)-forward (5'-CAGCATCACCCCTTTGTTTG-3') 
Asb2 (extended ex6)-reverse (5'-CCTGGCCTAAGAGTCCTCCA-3') 
Fbxo40-forward (5'-AGAAGCCAGAAGCAGGGAAG-3') 
Fbxo40-reverse (5'-GCTCCACGATGTTGAAAGGA-3') 
Nrap-forward (5'-TGTTGCTTCTCCCTGTCTCC-3') 
Nrap-reverse (5'-GGCTGCCACAGACTTCTTCA-3') 
Eif4a2-forward (5'-TGACGTGCAACAAGTGTCCT-3') 
Eif4a2-reverse (5'-CCACACCTTTCCTCCCAAA-3') 
 
RNA sequencing 
For the preparation of cDNA library, total RNA was extracted from the heart of 6 weeks-old 
mice (n = 2) using ISOGEN II (Nippon Gene, #311-07361). Ribosomal RNA (rRNA) was 
removed using RiboMinus Eukaryote Kit (Thermo Fisher Scientific, #A1083708). Depletion of 
rRNA was confirmed using the Agilent 2100 Bioanalyzer (Agilent Technologies). cDNA 
libraries were then prepared using SOLiD total RNA-Seq kit (Thermo Fisher Scientific, 
#4445374) in accordance with the manufacturer's instructions. Briefly, rRNA-depleted RNA 
was fragmented by RNase III, and subsequently incubated with T4 polynucleotide kinase. After 
purification of fragmented RNA, the size of fragmented RNA was determined using the Agilent 
2100 Bioanalyzer. Fragmented RNA was ligated to SOLiD adaptor, and reverse transcribed by 
ArrayScript reverse transcriptase (Thermo Fisher Scientific). The cDNA was purified using 
Agencourt AMPure XP (Beckman Coulter), and amplified by 15 cycles of PCR using SOLiD 
barcoded 3' primers. Amplified cDNA was purified and size-selected using Agencourt AMPure 
XP. The quality of the cDNA library was checked by the Agilent 2100 Bioanalyzer, and 
quantified by TaqMan qPCR. RNA sequencing was carried out using the 5500xl SOLiD system 
(Thermo Fisher Scientific) in the single-end sequencing mode (75 bp reads) in accordance with 
the manufacturer's instructions. 
   The data were imported into CLC Genomics Workbench software (v9.5.3, Qiagen), and 
mapped to the mouse genome (GRCm38) using RNA-sequencing analysis tool. Transcript 
expression was analyzed against 83,260 transcript models downloaded from the CLC website. 
Quantification value for each transcript was obtained in RPKM (reads per kilobase per million 
reads), and used for empirical analysis of DGE in CLC Genomics Workbench. RNA isoforms 
were filtered based on significant expression changes (p < 0.05) between control and 
PRMT1-cKO mice samples. Relative expression of isoforms between two groups was then 
compared by calculating isoform ratio in the following manner: 
Relative RPKM = transcript-specific RPKM / total RPKM from transcript isoforms 
(means of N=2, respectively) 
Isoform ratio = Relative RPKM in WT / Relative RPKM in cKO 
By filtering for changes at least 2.0-fold, 82 transcripts (74 genes) were selected as candidate 
splicing regulation events. To visually confirm these splicing events, BAM files were exported 
from CLC Genomics Workbench, sorted, imported to into the Integrative Genomics Viewer 
(IGV), and Sashimi plot images were created. 
 
Data and software availability 
The accession number for the data reported in this study is GEO: GSE112938. 
 
Gene ontology (GO) analysis 
GO overrepresentation test was performed using the PANTHER web tool (http://pantherdb.org). 
The gene list (74 genes) was uploaded and analyzed by statistical overrepresentation test 
(Fisher's Exact with FDR multiple test correction; Annotation Version and Release Date: GO 
Ontology database Released 2018-07-03). 
 
Cell culture 
C2C12 mouse myoblasts were grown in DMEM supplemented with 10% FBS and PS (growth 
medium). Cell differentiation was induced by switching from growth medium to DMEM 
containing 2% horse serum and PS. At three days after induction of differentiation, cells were 
collected and used for mRNA experiment.  
 
Transfection and immunoprecipitation assay 
To investigate the function of eIF4A2 isoforms, mouse eIF4A2 isoforms were amplified by 
PCR from heart cDNA and inserted into pHA-C1 vector.  
The primers for cDNA cloning were as follows:  
XhoI-eIF4A2-forward (5'-CCGCTCGAGCTATGTCTGGTGGCTCCGCGGA-3')  
eIF4A2-wt-BamHI-reverse (5'-CGCGGATCCTTAAATTAGGTCAGCCACAT-3')  
eIF4A2-tr-BamHI-reverse (5'-CGCGGATCCCTATCGACTCCTGTGAATAT-3') 
   For detecting ubiquitination, plasmids were transfected into C2C12 cells using 
Lipofectamine LTX (Thermo Fisher Scientific, #5338100) in accordance with the 
manufacturer's instructions. After 16 hours incubation, cells were treated with MG132 (10 µM 
final concentration, Enzo Life Sciences, #BML-PI102-0005) for 8 hours. Cells were lysed in 
ice-cold TNE buffer containing 0.1% Triton X-100. After centrifugation, the supernatants were 
incubated overnight with anti-HA antibody (Roche, #11867423001) at 4ºC. To collect the 
immunocomplex, SureBeads Protein G Magnetic Beads (Bio-Rad, #1614023) were added to 
samples. After incubation for 1 hour at 4ºC, the beads were washed three times with lysis buffer, 
2xSDS sample buffer was added, and incubated for 5 minutes at 99°C. Immunoblot was 
performed using following primary antibodies: anti-HA (1:2000, mouse-monoclonal, Wako, 
#014-21881), anti-ubiquitin (1:500, mouse-monoclonal, Santa Cruz Biotechnology, #sc-8017), 
anti-β-actin (1:2000, rabbit-polyclonal, Medical & Biological Laboratory, #PM053). 
 
Statistical analysis 
Statistical analysis was performed using GraphPad Prism 5 (GraphPad Prism Software). The 
data were analyzed using Student’s t-test and Mann Whitney test, and two-way ANOVA 
followed by Bonferroni multiple comparison test. Significant differences were defined as p < 
0.05.
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